Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CACI International Inc filings document the formal disclosures of an operating national security technology company serving U.S. government defense, intelligence and federal civilian customers. Recent Form 8-K reports cover fiscal-quarter results, financial-condition disclosures, material agreements and exhibits tied to the company's operating performance and contract-driven business.
The filing record also documents capital-structure actions, including unsecured senior notes due 2033, related subsidiary guarantees and financing arrangements connected to the completed ARKA Group acquisition. Other disclosures address accounts receivable purchase arrangements, board composition, director independence, compensatory arrangements and other governance matters reported under current-report requirements.
CACI International director Susan M. Gordon reported a routine equity compensation vesting. On January 14, 2026, 84 Restricted Stock Units (RSUs) previously granted to her converted into CACI common stock at an exercise price of $0 per share. These RSUs are part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four installments through October 11, 2026.
Following this transaction, Gordon directly beneficially owned 2,821 shares of CACI common stock and 254 RSUs, reflecting ongoing board compensation rather than an open-market purchase or sale.
CACI International director Stanton D. Sloane reported the vesting of 84 Restricted Stock Units (RSUs) into 84 shares of CACI common stock on January 14, 2026, at an exercise price of $0 per share. After this transaction, he beneficially owned 943 shares of CACI common stock and 254 RSUs directly.
These RSUs are part of a 338-unit grant awarded on October 17, 2025, with a scheduled vesting of 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Lisa Disbrow reported equity awards tied to her board service. On January 14, 2026, 123 Restricted Stock Units (RSUs) vested and were settled into 123 shares of CACI common stock, leaving her with 2,110 directly held shares and 369 RSUs still outstanding from a 492-unit grant made on October 16, 2025. On January 15, 2026, she received an additional 44 shares of common stock in connection with her annual retainer as Chair of the Board, bringing her direct holdings to 2,154 shares.
CACI International Inc. director Debora A. Plunkett reported the vesting of restricted stock units and corresponding issuance of common shares. On January 14, 2026, 84 Restricted Stock Units converted at an exercise price of $0.0000 per unit into 84 shares of CACI common stock, reported as a transaction with code "M." Following this transaction, she directly held 2,648 shares of CACI common stock and 254 Restricted Stock Units.
The footnote explains that on October 17, 2025, she was granted 338 Restricted Stock Units, scheduled to vest in four installments: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Ryan D. McCarthy reported the vesting and settlement of restricted stock units into common stock. On January 14, 2026, 84 Restricted Stock Units (RSUs) converted into 84 shares of CACI common stock at a reported price of $0.00 per share, reflecting a routine equity award vesting.
These RSUs were part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. After this transaction, McCarthy directly beneficially owned 2,153 shares of CACI common stock and 254 RSUs, all reported as directly held.
CACI International Inc. director David F. Keffer filed an initial ownership report on Form 3. The filing states that, as of the event date of 01/01/2026, he beneficially owns no securities of CACI International Inc. This confirms his role as a director while disclosing that he holds no direct or indirect equity or derivative positions in the company’s stock.
CACI International Inc reported changes to its board of directors. On December 24, 2025, William L. Jews informed the company he will resign from the board effective December 31, 2025, and his resignation is stated not to result from any disagreement regarding the company’s operations, policies, or practices.
On December 29, 2025, the board appointed Michael Gilday and David Keffer as directors effective January 1, 2026, filling the vacancies created by Mr. Jews’ resignation and the earlier passing of director Michael A. Daniels. The board determined both new directors meet New York Stock Exchange independence requirements and are independent of the company. They will serve initial terms expiring at the next annual meeting of shareholders, receive the standard non‑employee director compensation, and there are no related‑party arrangements requiring disclosure.
CACI International Inc disclosed that its wholly owned subsidiary CACI, Inc. – Federal and certain other subsidiaries entered into Amendment No. 7 to the existing Master Accounts Receivable Purchase Agreement with MUFG Bank, Ltd. and certain purchasers. The amendment extends the agreement’s Scheduled Termination Date from December 19, 2025 to December 18, 2026 and also changes certain commercial terms of the arrangement. This keeps the company’s receivables purchase structure in place for an additional year under revised business provisions.
CACI International Inc agreed that its subsidiary CACI, Inc.-Federal will acquire ARKA Group, L.P. for an aggregate cash purchase price of $2.6 billion, subject to customary post-closing adjustments. The structure includes an initial purchase of partnership interests held by a blocker entity, followed by a merger of Spatium Merger Sub, LLC into ARKA Group, which will then become an indirect wholly owned subsidiary of CACI.
The agreement includes customary representations, warranties, covenants and closing conditions, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act. The transaction may be terminated if it has not closed by June 19, 2026, subject to limited extension rights, and is expected to close in the third quarter of CACI’s 2026 fiscal year. CACI plans to fund the deal with cash on hand, borrowings under its revolving credit facility and additional debt, supported by a commitment from Wells Fargo for a senior secured bridge loan facility of up to $1.3 billion.
CACI has a Rule 144 notice covering a planned sale of its common stock.
A shareholder intends to sell 10168 shares of common stock through UBS Financial Services, Inc. on the NYSE, with an approximate sale date of 12/16/2025 and an aggregate market value of 5745326.00. The notice states that these 10168 shares were acquired on 10/01/2024 via RSU vestings from the issuer. It also lists 22079710 shares of this class outstanding.